Resignation of Mr. Dhananjay Sabaji Hatle as Executive Director of the company w.e.f. Jun 05, 2025
As filed · Bajaj Healthcare Limited has informed the Exchange regarding Resignation of Mr. Dhananjay Sabaji Hatle as Executive Director of the company w.e.f. Jun 05, 2025.
What happened
FactBajaj Healthcare Limited has announced the resignation of Mr. Dhananjay Sabaji Hatle as Whole-Time Director, effective immediately, as per his letter dated June 05, 2025. The company has provided the necessary disclosures in accordance with SEBI regulations. The resignation letter is attached as an annexure to the filing.
Why it matters
CapitSignal interpretationThe CEO/MD sets the strategy that existing guidance was built on; a change puts that guidance up for revision.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedEBITDA and overall profitability improved during the year, with PAT margin from continuing operations before exceptional items rising to 8.8% compared to 7.9% in FY25.
Gross profit for the quarter stood at INR80.4 crores, up by 16.2% year-on-year compared to INR69.1 crores in Q1 FY26.
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Whether previously stated targets are reaffirmed
- Internal promotion versus external hire
- Any change to capital-allocation plans
- We completed the construction of a plant with the capacity to process approximately 250 MT of opium gum and ab (management committed by FY29)
Evidence
- Bajaj Healthcare Limited has informed the Exchange regarding Resignation of Mr. Dhananjay Sabaji Hatle as Executive Director of the company w.e.f. Jun 05, 2025.(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- CEO_MD_CHANGE base 62; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%